A detailed history of Franklin Resources Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Franklin Resources Inc holds 53,345 shares of MYGN stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,345
Previous 46,112 15.69%
Holding current value
$1.51 Million
Previous $983,000 32.66%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.98 - $25.47 $130,049 - $184,224
7,233 Added 15.69%
53,345 $1.3 Million
Q1 2024

May 13, 2024

BUY
$17.59 - $23.59 $87,914 - $117,902
4,998 Added 12.16%
46,112 $983,000
Q4 2023

Feb 09, 2024

SELL
$13.91 - $21.32 $20,266 - $31,063
-1,457 Reduced 3.42%
41,114 $786,000
Q3 2023

Nov 13, 2023

BUY
$15.99 - $23.22 $5,180 - $7,523
324 Added 0.77%
42,571 $682,000
Q2 2023

Aug 11, 2023

BUY
$17.56 - $23.76 $741,857 - $1 Million
42,247 New
42,247 $979,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.28B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.